Skip to main content
2024 ISPE Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Evaluation

Assessing COVID-19 Vaccine Effectiveness

Tuesday, August 27, 2024
8:00 AM – 9:30 AM CEST
Location:Conv Hall I C

Presentations:

  • 8:00 AM – 8:15 AM CEST
    Drug target Mendelian Randomisation vs propensity score weighting for causal inference: estimating vaccine-induced antibody effect on COVID-19 outcomes

    Presenting Author: Junqing Xie, MBBS, MSc, DPhil (he/him/his) – University of Oxford

    Co-Author: Marta Alcalde Herraiz – University of Oxford

    Co-Author: Danielle Newby, PhD – University of Oxford

    Co-Author: Stephen Burgess – MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom

    Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford

  • 8:15 AM – 8:30 AM CEST
    Added Benefit and Waning Effectiveness of a Third-Dose mRNA COVID-19 Vaccine in Community-Dwelling Medicare Beneficiaries Aged ≥65 Years in Omicron Period

    Co-Author: Yun Lu, PhD – Center for Biologics Evaluation and Research, Food and Drug Administration

    Co-Author: Kathryn Matuska, BA – Acumen, LLC

    Presenting Author: Rowan McEvoy, B.S. – Acumen, LLC

    Co-Author: Hector S. Izurieta, MD, PhD – US Food and Drug Administration

    Co-Author: Jessica R. Hervol, MPH – Acumen, LLC

    Co-Author: Mikhail Menis, PharmD, MS (he/him/his) – Center for Biologics Evaluation and Research, Food and Drug Administration

    Co-Author: Arnstein Lindaas, MA – Acumen, LLC

    Co-Author: Whitney Steele, PhD – Center for Biologics Evaluation and Research, U.S. Food and Drug Administration

    Co-Author: Yoganand Chillarige, MPA – Acumen LLC

    Co-Author: Michael Wernecke, BA (he/him/his) – Acumen, LLC

    Co-Author: Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA

    Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA

  • 8:30 AM – 8:45 AM CEST
    Considerations for Negative Control Outcome Analyses in Vaccine Effectiveness Studies: Post-Hoc Analyses from an Adult Vaccine Effectiveness Study conducted within the FDA BEST Initiative

    Presenting Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology

    Co-Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health

    Co-Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions

    Co-Author: Jie Deng – Optum Epidemiology

    Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health

    Co-Author: Morgan M. Richey, Ph.D, MPH – RTI International

    Co-Author: Rachel P. Ogilvie, PhD, MPH – Optum Epidemiology

    Co-Author: Ron J. Parambi, MBBS, MPH – Optum

    Co-Author: Michael Miller, n/a – Optum Life Sciences

    Co-Author: Jennifer Song, MA, MURP – United Health Group

    Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve

    Co-Author: Lisa B. Weatherby – Optum Epidemiology

    Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute

    Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions

    Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health

    Co-Author: Grace W. Yang – OptumServe

    Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health

    Co-Author: Kandace L. Amend, PhD – Optum Epidemiology

  • 8:45 AM – 9:00 AM CEST
    Effectiveness of COVID-19 vaccines administered during pregnancy in Spain and Norway

    Presenting Author: Núria Mercadé-Besora, MS – University of Oxford

    Co-Author: Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

    Co-Author: Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

    Co-Author: Berta Raventós, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)

    Co-Author: Theresa Burkard, PhD (she/her/hers) – University of Oxford

    Co-Author: Edward Burn, PhD – University of Oxford

    Co-Author: Martí Català, PhD (he/him/his) – University of Oxford

    Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway

    Co-Author: Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)

    Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway

    Co-Author: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol

  • 9:00 AM – 9:15 AM CEST
    Innovative Self-controlled Risk Interval Analysis of Effectiveness of COVID-19 mRNA Booster Vaccination in the Veterans Health Administration, Omicron Predominant Period

    Co-Author: Caroline Korves, ScD – White River Junction Veterans Affairs Medical Center

    Co-Author: Martin Kulldorff, PhD – Acumen, LLC

    Co-Author: Abirami S. Balajee, MPH – White River Junction Veterans Affairs Medical Center

    Co-Author: Jeremy Smith, MPH – White River Junction Veterans Affairs Medical Center

    Co-Author: Gabrielle M. Zwain, BA – White River Junction Veterans Affairs Medical Center

    Co-Author: David J. Graham, MD, MPH – US Food and Drug Administration

    Co-Author: Jurandir Dalle Lucca, MD, PhD – White River Junction Veterans Affairs Medical Center

    Presenting Author: Hector S. Izurieta, MD, PhD – US Food and Drug Administration

  • 9:15 AM – 9:30 AM CEST
    Effectiveness Over Time of a Complete Primary Series of the Original, Monovalent COVID-19 Vaccines Among Adults Aged 18-64 Years in the United States

    Presenting Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions

    Co-Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology

    Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration

    Co-Author: Yixin Jiao – Acumen, LLC

    Co-Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health

    Co-Author: Jie Deng – Optum Epidemiology

    Co-Author: Joann F. Gruber, PhD, MSPH – US FDA

    Co-Author: Rachel P. Ogilvie, PhD, MPH – Optum Epidemiology

    Co-Author: Ron J. Parambi, MBBS, MPH – Optum

    Co-Author: Michael Miller, n/a – Optum Life Sciences

    Co-Author: Jennifer Song, MA, MURP – United Health Group

    Co-Author: Lisa B. Weatherby – Optum Epidemiology

    Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute

    Co-Author: An-Chi Lo – Acumen, LLC

    Co-Author: Jessica R. Hervol, MPH – Acumen, LLC

    Co-Author: Michael Wernecke, BA (he/him/his) – Acumen, LLC

    Co-Author: Sylvia Cho, PhD – US FDA

    Co-Author: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration

    Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA

    Co-Author: Christine L. Bui, MPH – RTI-HS

    Co-Author: Alexandra Stone, PhD, MSc – Optum Serve

    Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve

    Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health

    Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA

    Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration

    Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health

    Co-Author: Kandace L. Amend, PhD – Optum Epidemiology

    Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health

    Co-Author: Yoganand Chillarige, MPA – Acumen LLC

    Co-Author: Grace W. Yang – OptumServe

    Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions

    Co-Author: Azadeh Shoaibi, PhD, MHS – FDA